The Next Threat to Rural Healthcare Isn’t the Big Beautiful Bill – RedState

0
122

The Democrats have decided that they want to make the One Big Beautiful Bill their primary campaign talking point in 2026. They think that by focusing on Medicaid cuts, they can scare voters away from the Republican Party and back toward them for the midterms.





One of their focus points is how Medicaid cuts might impact rural hospitals. But the Democrats are also big proponents of doing away with the 340B drug program that those same hospitals rely on, and they aren’t lifting a finger to stop big pharmaceutical companies from trying to gut it however they can.

What’s Really Happening

Five major pharmaceutical companies—Bristol Myers Squibb, Eli Lilly, Johnson & Johnson, Novartis, and Sanofi—are pushing to fundamentally change how rural hospitals get discounted drugs. Instead of getting upfront discounts through the federal 340B program, these companies…

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here